XRTX XORTX Therapeutics Inc: Accounting Value per Share

Graphic logo of XORTX Therapeutics Inc. (XRTX)

The net book value per share confirms the scaling potential of renal pathology therapies via patent leverage for XORTX Therapeutics Inc. (XRTX). The current level of 3.20 reflects the parameter's status amid a lack of capital expenditures due to production outsourcing. Meanwhile, XORTX Therapeutics Inc. (XRTX) aims to secure leadership in its niche, outpacing financially powerful competitors in the race for drug approval.

XORTX Therapeutics Inc (XRTX): Share Book Value from 07/04/2022 to 10/29/2026

xortx.com - analytical breakdowns and key metrics (XRTX)

- price and consensus price forecast:
Stock Quotes XORTX|XRTX - Analyst Forecast Prices
- market capitalization data:
Market Valuation XORTX Therapeutics Inc.|XRTX - Business Value
- book capitalization data:
Net Assets per Single Share XORTX Therapeutics|XRTX - Net Asset Value|Market Capitalization to Book Value Ratio xortx.com|XRTX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital XORTX Therapeutics Inc.|XRTX - Long-Term Debt to Capital|Short-Term Debt to Equity XORTX Therapeutics|XRTX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio XORTX Therapeutics Inc.|XRTX - Company Long-Term Liabilities|Company Short-Term Debts XORTX Therapeutics
Fundamental company valuation:XORTX - XRTX
Manufactured products of XORTX Therapeutics

Book value per share determines the net asset value minus all liabilities, serving as an indicator of the business's actual margin of safety and its resilience against bankruptcy. By analyzing the current book value per share, an investor assesses the capital efficiency of XORTX Therapeutics Inc. in creating a long-term patent margin within the renal failure therapy segment, where demand is guaranteed.

Competitors of XORTX Therapeutics Inc. (XRTX)

Accounting Value per Share Argenx ARGX|BioNTech Pharma (BNTX) - Book Price of a Share|Accounting Value per Share Abivax Corp|ADMA (admabiologics.com) - Equity per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|ANAB - Net Asset Value per Share|Astria Pharma (ATXS) - Accounting Value per Share|ENGN: Equity per Share|Net Assets per Single Share RAPT|JBIO (Aerovate Therapeutics) - Net Asset Value per Share|ACRS - Net Assets per Single Share|Accounting Value of a Share Kyverna Therapeutics Inc. (KYTX)|Accounting Value per Share Tiziana Life Sciences PLC|Book Price of a Share Cabaletta Bio Inc CABA|VTYX - Accounting Value per Share|THTX - Equity per Share|Accounting Value per Share Avalo Therapeutics (AVTX)|Eledon Pharmaceuticals Inc. (ELDN) - Accounting Value of a Share|AGEN - Accounting Value per Share|Climb Bio, Inc (CLYM) - Book Price of a Share|ZURA - Book Value per Share|Accounting Value of a Share atyrpharma.com|Adagene - Book Value per Share|Net Asset Value per Share IMA (ikenaoncology.com)|Net Assets per Single Share Shattuck Labs|Accounting Value of a Share Equillium Inc EQ|Connect Pharma - Book Value per Share|IMUX: Book Value per Share|Net Assets per Single Share atarabio.com (ATRA)|InflaRx (IFRX) - Share Book Value|Book Value per Share XFOR (X4 Pharma)|Net Asset Value per Share Adicet (ACET)|Accounting Value per Share CELU|Book Value per Share inmunebio.com INMB|Accounting Value per Share Barinthus Biotherapeutics plc (BRNS)|Book Price of a Share Kezar Life Sciences Inc. KZR|Book Value per Share SABS (SAB Biotherapeutics, Inc)|AKTX - Net Assets per Share|ENLV (enlivex.com) - Book Value per Share|QTTB (Q32 Bio) - Accounting Value per Share|GOVX: Net Assets per Single Share|Net Assets per Share Edesa Biotech Inc (EDSA)|iBio Corp (IBIO) - Accounting Value per Share|Accounting Value of a Share carismatx.com (CARM)|Book Value per Share XTLB|Bolt Biotherapeutics Inc. - Net Assets per Share|HCW Biologics Inc (HCWB) - Net Assets per Single Share|APVO - Equity per Share|AIM (AIM ImmunoTech) - Book Value per Share|Accounting Value per Share Aditxt, Inc.|GRI: Accounting Value per Share|Net Assets per Share reshapelifesciences.com (HIND)|Accounting Value per Share Revelation Biosciences, Inc. REVB|Equity per Share INDP (Indaptus Therapeutics Inc)|Net Assets per Single Share Scinai|CALI - Accounting Value of a Share|Accounting Value per Share Affimed Therapeutics AFMD|Allakos Inc. (ALLK) - Book Price of a Share|Accounting Value per Share hookipapharma.com|IGMS (IGM Biosciences) - Equity per Share|Net Assets per Single Share iTeos ITOS|Share Book Value Ocean Biomedical Corp|TC Biopharm (TCBP) - Book Value per Share|Accounting Value of a Share thirdharmonicbio.com (THRD)